Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hyperglycemia
Phenotype |diabetes
Sentences 383
PubMedID- 23209929 It has also been suggested that chronic exposure to hyperglycemia and hyperinsulinemia, in patients with type 2 diabetes, could contribute to the proliferation of hepatic stem cells, at higher risk for malignant transformation [10].
PubMedID- 26345606 Persistent hyperglycemia in patients with diabetes mellitus is said to be associated with various complications.
PubMedID- 21525446 diabetes is associated with hyperglycemia-specific microvascular complications.
PubMedID- 25284699 Glucagon-like peptide-1 receptor (glp-1) agonists and dipeptidyl-peptidase-4 (dpp-4) inhibitors are therapies that are used to treat hyperglycemia in patients with type 2 diabetes mellitus.
PubMedID- 24194733 In diabetes, reduction of endothelial no-levels, systemic hyperglycemia if uncontrolled, generation of reactive oxygen species, oxidative stress, and increased ldl-oxidation, formation of ages, and increased circulating free fatty acids are factors that add to atherosclerosis and cvd risk.
PubMedID- 24324393 While frank autonomic neuropathy almost certainly contributes to the altered vagal sensory and motor functions observed in chronic diabetes, the actions of acute hyperglycemia to modulate vagal afferent and efferent functions (macgregor et al., 1976; shi et al., 2003; takahashi et al., 2003; zhou et al., 2008) suggests that poor glycemic control per se also negatively impacts vagal reflex functions.
PubMedID- 22911800 hyperglycemia in diabetes mellitus damages blood vessels and induces vascular complications in the retinal, renal, and cardiovascular tissues [1], [2].
PubMedID- 21115766 We hypothesized that postbreakfast hyperglycemia in subjects with type 2 diabetes could be improved nonpharmacologically by using a high-protein, low-carbohydrate prebreakfast snack.
PubMedID- 26171401 However, whether the use of exogenous insulin (i.e., human insulin or insulin analogues) for treating hyperglycemia in patients with diabetes actually increases the risk of breast cancer is the subject of recent debate [18–20].
PubMedID- 20103560 Recent trials on the prevention of cvd events by the treatment of hyperglycemia in patients with type 2 diabetes have been disappointing.
PubMedID- 25756053 We conclude that hyperglycemia, which results from maternal diabetes and precedes embryo implantation, deregulates the intrauterine developmental timeline, restricts embryo-fetal growth, and primarily delays the remodeling and maturation of the structures derived from neural crest cells.
PubMedID- 22128218 It has been shown that the hyperglycemia associated with diabetes mellitus results in the activation of neutrophils(51) and that this activation contributes to an increase in oxidative stress that is partly responsible for diabetes complications.
PubMedID- 21172030 Agents that modulate bile acids may potentially affect both cholesterol and glucose metabolism, and hence dyslipidemia and hyperglycemia, in patients with type 2 diabetes [69,71,72].
PubMedID- 24716195 An increase of cardiovascular diseases due in part to hyperglycemia is associated with diabetes, which can induce endothelial dysfunction [2].
PubMedID- 22296854 Conclusions: the present results provide first evidence indicating that ems is a new exercise method for treating postprandial hyperglycemia in individuals with type 2 diabetes, especially who cannot perform adequate voluntary exercise because of excessive obesity, orthopedic diseases, or severe diabetic complications.
PubMedID- 24864247 hyperglycemia in diabetes can cause up to a 4-fold increase in neuronal glucose levels.
PubMedID- 23166623 Type 2 diabetes (t2d) is associated with dyslipidemia, hyperglycemia, insulin resistance, and defects in insulin secretion from pancreatic beta cells [1].
PubMedID- 24067431 Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces hyperglycemia in patients with diabetes and normal or mildly impaired renal function.
PubMedID- 23557386 Conclusions: high-dose prednisone for 2 to 3 months produced an elevated incidence of diabetes, usually with mild hyperglycemia occurring between the second and fourth week, normalizing spontaneously in all cases.
PubMedID- 21282368 Recently, we have shown that serum vap-1 is elevated in acute and chronic hyperglycemia and in patients with diabetes (13).
PubMedID- 24717767 Abnormal regulation of glucagon secretion has been implicated in the development of hyperglycemia in patients with type 2 diabetes mellitus [16], and a recent study in animal models indicated that a reduction in glucagon action can have profound effects on mitigating hyperglycemia even in the presence of severe hypoinsulinemia [17].
PubMedID- 23915015 Background: depression is common in diabetes and associated with hyperglycemia, diabetes related complications and mortality.
PubMedID- 22361035 Chronic hyperglycemia in diabetes leads to free radicals overproduction, which contributes to the development of diabetic nephropathy.
PubMedID- 21912542 Here, we detail the strategies that our institutions have employed to identify and treat hyperglycemia in patients with diabetes who present for surgery.
PubMedID- 26084668 However, the optimal treatment of hyperglycemia in patients with diabetes to reduce the progression of hf has not been well studied.
PubMedID- 21039714 hyperglycemia associated with diabetes was pronounced after excision of the tumor and had been masked by the paraneoplastic effect of the tumor.
PubMedID- 23250800 Our aim was to determine if increased nitric oxide generation by l-arginine infusion would reverse this deleterious response to clamped hyperglycemia in women with type 1 diabetes mellitus.
PubMedID- 23452437 These results suggest that the progression of atherosclerosis might be directly dependent upon hyperglycemia in patients with established diabetes status [15,16] but might be influenced by multiple cv risk factors, especially the component of increased blood pressure [17], in patients with a status of ms without diabetes.
PubMedID- 23799024 The vascular complications in diabetes are causally associated with hyperglycemia-induced ros overproduction and a large body of evidence has suggested that endothelial dysfunction is caused by ros [22].
PubMedID- 24089511 Glp-1 agonists have been incorporated into standard algorithms to treat hyperglycemia in patients with type 2 diabetes, and while the objective of these treatment regimens is to reduce glycemia safely (2), the importance of specifically targeting postprandial glycemia is increasingly being recognized (3).
PubMedID- 25935773 The clinical management of hyperglycemia in pregnancy complicated by maturity-onset diabetes of the young.
PubMedID- 24516103 Dipeptidyl peptidase-4 inhibitors prevent the degradation of incretin hormones and reduce postprandial hyperglycemia in patients with type 2 diabetes mellitus.
PubMedID- 21464443 Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling.
PubMedID- 20876838 Managing hyperglycemia in patients with type 2 diabetes mellitus: rationale for the use of dipeptidyl peptidase-4 inhibitors in combination with other oral antidiabetic drugs.
PubMedID- 22187370 Type 1 diabetes presents clinically with overt hyperglycemia resulting from progressive immune-mediated destruction of pancreatic beta-cells and associated metabolic dysfunction.
PubMedID- 24224091 Several factors such as dyslipidemia or hyperlipidemia which are involved in the microvascular and macrovascular complications as well as hyperglycemia are associated with the diabetes disease which is the major cause of morbidity and death [4].
PubMedID- 23267675 Twenty-two technical knowledge questions involved such concepts as the target age for diabetes testing, the benefits of exercise, hyperglycemia, groupings of foods and their exchange list, ideal body weight, and ketoacidosis.
PubMedID- 22196774 His laboratory blood values showed a non-regulated diabetes mellitus with hyperglycemia of 32 mmol/l, white blood cell count of 18 × 109/l with 81.6% polymorphonuclear cells (pmns), elevated c-reactive protein (crp), hemoglobin, sodium and creatinine.
PubMedID- 23087670 Persistent hyperglycemia in patients with diabetes may activate another lipogenic transcription factor, carbohydrate response element binding protein (chrebp; iizuka et al., 2004; dentin et al., 2006; ma et al., 2006; postic et al., 2007; davies et al., 2008).
PubMedID- 21386984 hyperglycemia in diabetes can cause up to four-fold increases in neuronal glucose levels.
PubMedID- 21115767 Type 1 diabetes leads to hyperglycemia, which is linked to a number of acute (e.g., diabetic ketoacidosis) and chronic (e.g., diabetic nephropathy and cardiovascular disease) complications (1).
PubMedID- 26398746 Nevertheless, the long-term consequence of elevated pkc-phosphorylation/activity should be considered in diabetes with chronic hyperglycemia [16].
PubMedID- 26317347 Agonist-induced activation of pparγ has been demonstrated to increase insulin sensitivity [25, 26] and thiazolidinediones (tzd) are used clinically to reduce insulin resistance and hyperglycemia in patients with type 2 diabetes, although these drugs are also associated with weight gain [27–31].
PubMedID- 22580727 The pathogenesis of nafld remains obscure, but it has been hypothesized that hepatic fat accumulation in type 1 diabetes may be due to lipoprotein abnormalities, hyperglycemia-induced activation of the transcription factors carbohydrate response element-binding protein (chrebp) and sterol regulatory element-binding protein 1c (srebp-1c), upregulation of glucose transporter 2 (glut2) with subsequent intrahepatic fat synthesis, or a combination of these mechanisms.
PubMedID- 24990094 The relationship between hyperglycemia (including diabetes) and periodontal disease (pd) has been noted previously, but its temporal sequence in the same study based on a population-based study has been barely addressed.
PubMedID- 23690866 In addition, high fructose consumption progresses to dietary model of type 2 diabetes that is associated with obesity, ir, hyperglycemia, and dyslipidemia [2].
PubMedID- 20413513 The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor incb13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy.
PubMedID- 24404519 While many studies have reported that psychiatric stress aggravates hyperglycemia in diabetes [3], the pattern and extent of hyperglycemia induced by psychiatric stress and the difference in the amount of psychiatric stress-induced hyperglycemia between normal and diabetic subjects remain unknown.
PubMedID- 24671257 Moreover, the occurrence of peri-implantitis, bacteremia, or hyperglycemia in individuals with diabetes may be long-lasting; however, our electrochemical tests were carried out over the short term.
PubMedID- 22178606 In the latter, the process is further aggravated by hyperglycemia, leading to diabetes complications of cns.

Page: 1 2 3 4 5 6 7 8